Literature DB >> 29276243

Stability of Procainamide Injection in Clear Glass Vials and Polyvinyl Chloride Bags.

Ronald F Donnelly1.   

Abstract

OBJECTIVES: The objective of this study was to evaluate the chemical stability of procainamide hydrochloride, 100 mg/mL, when repackaged in clear glass vials or diluted to 3 mg/mL with normal saline and packaged in polyvinyl chloride (PVC) bags when stored at either 23°C and exposed to light (ETL) or 5°C and protected from light (PFL).
METHODS: Solutions were assayed using a stability-indicating high-performance liquid chromatography method. Samples (5 mL) were collected from triplicate containers on days 0, 7, 14, 21, 28, 56, 91, and 193. Color/clarity and pH changes were also monitored at each time interval.
RESULTS: During the study, all samples remained clear and there was only a slight pH change. The color of the solutions stored at 23°C intensified but did not correlate with a significant decrease in concentration, while solutions stored at 5°C remained unchanged. Solutions repackaged in glass vials were stable for 193 days when stored at 23ºC and ETL or 5ºC and PFL. When further diluted to 3 mg/mL with normal saline and packaged in PVC bags, procainamide was also stable for 193 days at either 23ºC and ETL or 5°C and PFL.
CONCLUSIONS: The stability of procainamide, 100 mg/mL, repackaged in clear glass vials was 193 days when stored at either 23ºC and ETL or 5ºC or PFL. If diluted further to 3 mg/mL with normal saline and packaged in PVC bags, the drug was also stable for 193 days at either 23ºC and ETL or 5°C and PFL.

Entities:  

Keywords:  drug stability; glass vials; high-performance liquid chromatography; normal saline; polyvinyl chloride bags; procainamide hydrochloride

Year:  2017        PMID: 29276243      PMCID: PMC5735750          DOI: 10.1177/0018578717724896

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  8 in total

1.  Alteration in prehospital drug concentration after thermal exposure.

Authors:  Dustin L Gammon; Shujun Su; Janet Jordan; Robert Patterson; Phillip J Finley; Cindy Lowe; Roger Huckfeldt
Journal:  Am J Emerg Med       Date:  2008-06       Impact factor: 2.469

2.  Stability of procainamide in 0.9% sodium chloride or dextrose 5% in water.

Authors:  H L Kirschenbaum; L J Lesko; R W Mendes; G P Sesin
Journal:  Am J Hosp Pharm       Date:  1979-11

3.  Complexation of procainamide with dextrose.

Authors:  V D Gupta
Journal:  J Pharm Sci       Date:  1982-09       Impact factor: 3.534

4.  Stability of esmolol hydrochloride in the presence of aminophylline, bretylium tosylate, heparin sodium, and procainamide hydrochloride.

Authors:  L J Schaaf; D H Robinson; G J Vogel; B G Wulf; K D Drda; J O Moses
Journal:  Am J Hosp Pharm       Date:  1990-07

5.  Chemical incompatibility between procainamide hydrochloride and glucose following intravenous admixture.

Authors:  A Sianipar; J E Parkin; V B Sunderland
Journal:  J Pharm Pharmacol       Date:  1994-12       Impact factor: 3.765

6.  Stability of amrinone and digoxin, procainamide hydrochloride, propranolol hydrochloride, sodium bicarbonate, potassium chloride, or verapamil hydrochloride in intravenous admixtures.

Authors:  C M Riley; P Junkin
Journal:  Am J Hosp Pharm       Date:  1991-06

7.  Stability of procainamide hydrochloride in neutralized 5% dextrose injection.

Authors:  G G Raymond; M T Reed; J R Teagarden; K Story; C W Geberbauer
Journal:  Am J Hosp Pharm       Date:  1988-12

8.  Irreversibility of procainamide-dextrose complex in plasma in vitro.

Authors:  D W Henry; J A Lacerte; N E Klutman; C M Riley
Journal:  Am J Hosp Pharm       Date:  1991-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.